Top Markets
#1 OSK OSK +15.39%
#2 MarsCoin MarsCoin +12.21%
#3 Tornado Cash Tornado Cash +6.73%
#4 HOME HOME +6.37%
#5 UnifAI Network UnifAI Network +4.86%
#6 AI XOVIA AI XOVIA +4.25%
#7 Pyth Network Pyth Network +3.64%
#8 Backpack Backpack +3.30%
#9 Story Story +3.06%
#10 Rain Rain +2.82%
Coin of the day
OSK OSK
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Adagio Therapeutics, Inc. Adagio Therapeutics, Inc.

Adagio Therapeutics, Inc.

ADGI
Hisse Senetlerindeki Sıralama #16435
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily... Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical firm, primarily focused on the discovery, development, and subsequent commercialization of antibody-based therapeutics designed to combat infectious diseases across the United States. Its most advanced product candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical trials. This antibody is being evaluated for both the treatment and prevention of coronavirus disease. Adagio Therapeutics also engages in strategic collaborations. It partners with Adimab, LLC to facilitate the discovery and optimization of novel proprietary antibodies. Furthermore, the company works with the Scripps Research Institute on research initiatives aimed at identifying vaccine candidates that could prevent, diagnose, or treat influenza and beta coronaviruses. Founded in 2020, Adagio Therapeutics maintains its headquarters in Waltham, Massachusetts.
Hisse Fiyatı
$4.64
Son senkronizasyon: 2022-09-12
Piyasa Değeri
$293.43M
Değişim (1 gün)
0.87%
Değişim (1 yıl)
0.00%
Ülke
US
Ticaret Adagio Therapeutics, Inc. (ADGI)

Kategori

Healthcare
Adagio Therapeutics, Inc. (ADGI) için kazanç
2026 itibarıyla kazanç TTM: 0
Adagio Therapeutics, Inc. şirketinin en son finansal raporlarına göre, mevcut kazancı 0'dir. 2026 yılında şirket 0 kazanç elde etti, bu 2026 yılındaki 0 kazanca göre önceki yıla eşit. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Adagio Therapeutics, Inc. için kazanç geçmişi 2026 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için kazanç
Şirket Kazanç Kazanç Farkı Ülke
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH